Reversible visual disturbance due to cryptococcal uveitis in a non-HIV individual.

A 52-year-old man without underlying diseases visited a local hospital with symptoms of memory deficit and mild headache. Radiological examination of the brain with computed tomography (CT) revealed hydrocephalus. Etiology was not revealed by cerebrospinal fluid (CSF) analysis and a ventricular-atrial (V-A) shunt was installed. The patient had congestion and dacryorrhea of the right eye and uveitis was diagnosed three months after placement of the V-A shunt. The serum cryptococcal antigen (CrAg) tested positive at a titration of 64 times. Additionally, samples of the right eye anterior chamber aqueous humor (ACAH), cerebrospinal fluid (CSF) and prostate fluid were positive for Cryptococcus antigen at a titration of 128 times. In addition, Cryptococcus neoformans var. grubii was isolated from the peripheral blood, CSF and ACAH, resulting in a diagnosis of disseminated cryptococcosis. Fluconazole (FLCZ) at 800 mg/day was administered for the first two days, followed by a 400 mg/day maintenance dose. After six months of treatment, his visual power recovered. This is a rare case of disseminated cryptococcosis involving uveitis, which was successfully treated by FLCZ. Disseminated cryptococcosis should be considered in cases with mild symptoms and V-A shunt installation for hydrocephalus.

[1]  A. Casadevall,et al.  Susceptibility of Cryptococcus neoformans Biofilms to Antifungal Agents In Vitro , 2006, Antimicrobial Agents and Chemotherapy.

[2]  K. Schmierer,et al.  Diagnostic pitfalls in eosinophilic cryptococcal meningoencephalitis , 2003, The Lancet Neurology.

[3]  M. Ghannoum,et al.  Effects of Fluconazole Singly and in Combination with 5-Fluorocytosine or Amphotericin B in the Treatment of Cryptococcal Meningoencephalitis in an Intracranial Murine Model , 2002, Journal of chemotherapy.

[4]  E. Gürsel,et al.  Penetration of topical fluconazole into human aqueous humor. , 2001, Experimental eye research.

[5]  D. Hospenthal,et al.  Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Michael H. Miller,et al.  Comparison of fluconazole pharmacokinetics in serum, aqueous humor, vitreous humor, and cerebrospinal fluid following a single dose and at steady state. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[7]  R. Mugerwa,et al.  Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. Ghannoum,et al.  Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  R. Allen,et al.  Cryptococcal ventricular-peritoneal shunt infection: clinical and epidemiological evaluation of two closely associated cases. , 1993 .

[10]  R. Allen,et al.  Cryptococcal Ventricular-Peritoneal Shunt Infection: Clinical and Epidemiological Evaluation of Two Closely Associated Cases , 1993, Infection Control & Hospital Epidemiology.

[11]  S. Elner,et al.  Cryptococcal endophthalmitis: case report and review. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  D. Denning,et al.  Endophthalmitis in a patient with disseminated cryptococcosis and AIDS who was treated with itraconazole. , 1991, Reviews of infectious diseases.

[13]  L. M. Tang,et al.  Ventriculoperitoneal shunt in cryptococcal meningitis with hydrocephalus. , 1990, Surgical neurology.

[14]  A. Friedman,et al.  Successful treatment of cryptococcal ventriculoatrial shunt infection with systemic therapy alone. , 1988, Neurosurgery.

[15]  M. Salcman,et al.  Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study. , 1986, Neurosurgery.

[16]  C. Crum,et al.  Cryptococcal peritonitis complicating a ventriculoperitoneal shunt in unsuspected cryptococcal meningitis. , 1981, Human pathology.